Feature Channels:

Vaccines

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

MRSA, Superbug, Staph

Investigators May Unlock Mystery of How Staph Cells Dodge the Body’s Immune System, Allowing Patients to Be Infected Again and Again

MRSAPhoto09-21-17.jpg

For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body’s immune system, offering a clearer picture of how a successful vaccine would work.

Medicine

Channels:

Virology, business economics, pharmaceutial science, Medicine & Health, Vaccines, Public Health, Immunology, Infectious Disease

Flu Vaccine Used in Elderly May Benefit Middle-Aged Adults with Chronic Conditions

Expanding the high-dose influenza vaccine recommendation to include middle-aged adults with chronic health conditions may make economic sense and save lives. The findings may justify for clinical trials of the high-dose and new recombinant trivalent influenza vaccines in 50- to 64-year-old adults with chronic illnesses, such as heart or lung disease, diabetes, or cancer, to determine if they do provide considerably better protection than the currently recommended standard dose quadrivalent vaccine.

Medicine

Channels:

mario sznol, Yale cancer, Cancer Vaccines

Scientists See Progress for Cancer Vaccines

Sznol2.jpg

Tumor-destroying vaccines have emerged as a new weapon in the fight against cancer.

Medicine

Channels:

Alzheimer's, Alzheimer's Disease, Prevention, Vaccine, Clinical Trial, Keck School Of Medicine Of Usc, USC, Lon Schneider, Generation Study, Apoe 4, Amyloid Beta, Clinical Drug Trials, Clinical Drug Development

New Study Investigates Vaccine and Oral Medication to Stop Alzheimer’s Years Before It Begins

amyloidforblog.jpg

The Keck School of Medicine of USC launches a new study investigating a vaccine and oral medication to stop Alzheimer’s years before it begins

Medicine

Channels:

Troubleshooters Drives the Extra Mile to Vaccinate the Community

karen-rasmussen.jpg

Karen Rasmussen knows the roadways and highways of Harris County too well. As driver for Harris Health System’s mobile immunization unit, she’s traveled nearly 30,000 miles in the last seven years crisscrossing the nation’s third largest county to vaccinate children.

Science

Channels:

Leishmaniasis, Global Warming, climate change and human health, Climate Change, Leishmania, Parasite, Vaccine, Vaccine Design, vaccine delivery, virus-like nanoparticles, virus-like particles , Phlebotomine sand fly, Epidemic diseases, visceral leishmaniasis, mucosal leishmaniasis, Mucosal Immunology, Parasitology, Immunology, alpha-GAL

As 'Flesh-Eating' Leishmania Come Closer, a Vaccine Against Them Does, Too

femalesandfly.jpg

Large boils, acid-like facial wounds, death by maiming of viscera. Leishmania parasites inflict suffering that is the stuff of parables. They're the second-deadliest parasites after malaria, and global warming is pushing them north. Can this new experimental vaccine someday stop them?

Medicine

Science

Channels:

San Diego, Palm Beach Florida, The Scripps Research Institute, Hiv Vaccine

TSRI Study Reveals New Clues to How a Successful HIV Vaccine Could Work

Scientists at The Scripps Research Institute (TSRI) have made a discovery that could speed efforts to develop a successful HIV vaccine.

Medicine

Channels:

Emergency, Preparedness, Disaster Preparedness, Public Health

AJPH Supplement Study Shows Considerable Progress in Public Health Emergency Preparedness Since September 11, 2001

In this month's release, find new embargoed research from a special AJPH supplement on public health emergency preparedness.

Medicine

Channels:

Checking Your Neck, Colon Cancer Screening, New Microfluidic Device, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

Medicine

Channels:

HPV

New Study Finds Improved Vaccine That Protects against Nine Types of HPV is Highly Effective

TAMPA, Fla. – Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer.







Chat now!